These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21635955)

  • 21. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
    Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M
    J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
    Soon D; Tozer D; Altmann D; Tofts P; Miller D
    Mult Scler; 2007 Aug; 13(7):884-94. PubMed ID: 17468443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis--preliminary results.
    Losseff NA; Miller DH; Kidd D; Thompson AJ
    Mult Scler; 2001 Feb; 7(1):23-5. PubMed ID: 11321189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting breakdown of the blood-brain barrier in multiple sclerosis without contrast agents.
    Shinohara RT; Goldsmith J; Mateen FJ; Crainiceanu C; Reich DS
    AJNR Am J Neuroradiol; 2012 Sep; 33(8):1586-90. PubMed ID: 22442041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis.
    Stone LA; Frank JA; Albert PS; Bash C; Smith ME; Maloni H; McFarland HF
    Ann Neurol; 1995 May; 37(5):611-9. PubMed ID: 7755356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI evolution of new MS lesions enhancing after different doses of gadolinium.
    Rovaris M; Mastronardo G; Gasperini C; Prandini F; Yousry TA; Filippi M
    Acta Neurol Scand; 1998 Aug; 98(2):90-3. PubMed ID: 9724005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
    Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections.
    Nagaraja TN; Nagesh V; Ewing JR; Whitton PA; Fenstermacher JD; Knight RA
    Magn Reson Imaging; 2007 Apr; 25(3):311-8. PubMed ID: 17371719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.
    Frank JA; Stone LA; Smith ME; Albert PS; Maloni H; McFarland HF
    Ann Neurol; 1994; 36 Suppl():S86-90. PubMed ID: 8017894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three subsequent single doses of gadolinium chelate for brain MR imaging in multiple sclerosis.
    Sardanelli F; Iozzelli A; Losacco C; Murialdo A; Filippi M
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):658-62. PubMed ID: 12695199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics.
    Saade C; Bou-Fakhredin R; Yousem DM; Asmar K; Naffaa L; El-Merhi F
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2168-2176. PubMed ID: 30385472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study.
    Silver NC; Tofts PS; Symms MR; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2001 Apr; 7(2):75-82. PubMed ID: 11424635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images.
    Hiehle JF; Grossman RI; Ramer KN; Gonzalez-Scarano F; Cohen JA
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):69-77. PubMed ID: 7900604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.